UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Anticholinergic exposure and its association with dementia/Alzheimer's disease and mortality in older adults

BMC geriatrics, 2023-06, Vol.23 (1), p.401-401, Article 401

2023

Volltextzugriff (PDF)

A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance

Drug safety, 2015-08, Vol.38 (8), p.749-765

2015

Volltextzugriff (PDF)

The Relationship Between Anticholinergic Exposure and Falls, Fractures, and Mortality in Patients with Overactive Bladder

Drugs & aging, 2019-10, Vol.36 (10), p.957-967

2019

Volltextzugriff (PDF)

Association of obesity with healthcare utilization and costs in a Medicare population

Current medical research and opinion, 2017-12, Vol.33 (12), p.2173-2180

2017

Volltextzugriff (PDF)

Effect of Potentially Inappropriate Use of Antimuscarinic Medications on Healthcare Use and Cost in Individuals with Overactive Bladder

Journal of the American Geriatrics Society (JAGS), 2016-04, Vol.64 (4), p.779-787

2016

Volltextzugriff (PDF)

Heart Failure Among Patients with Multiple Myeloma Treated with Carfilzomib-Based Versus Non–Carfilzomib-Based Regimens in the United States by Race

Clinical lymphoma, myeloma and leukemia, 2023-08, Vol.23 (8), p.616-625

2023

Volltextzugriff (PDF)

Impact of 2015 Update to the Beers Criteria on Estimates of Prevalence and Costs Associated with Potentially Inappropriate Use of Antimuscarinics for Overactive Bladder

Drugs & aging, 2017-07, Vol.34 (7), p.535-543

2017

Volltextzugriff (PDF)

Retrospective evaluation of an inpatient psychiatric pharmacist consultation service

Journal of the American Pharmacists Association, 2011-09, Vol.51 (5), p.599-604

2011

Volltextzugriff (PDF)

Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study

Drug safety, 2021-08, Vol.44 (8), p.899-915

2021

Volltextzugriff (PDF)

Household Members of Persons with Alzheimer's Disease: Health Conditions, Healthcare Resource Use, and Healthcare Costs

Journal of the American Geriatrics Society (JAGS), 2014-03, Vol.62 (3), p.435-441

2014

Volltextzugriff (PDF)

A prospective study of elderly initiating mirabegron versus antimuscarinics: Patient reported outcomes from the Overactive Bladder Satisfaction Scales and other instruments

Neurourology and urodynamics, 2018-01, Vol.37 (1), p.177-185

2018

Volltextzugriff (PDF)

Impact of Coexisting Overactive Bladder in Medicare Patients With Dementia on Clinical and Economic Outcomes

American journal of Alzheimer's disease and other dementias, 2019-11, Vol.34 (7-8), p.492-499

2019

Volltextzugriff (PDF)

Real-world treatment, clinical outcomes and healthcare resource utilization among persons with hemophilia A by age

Journal of comparative effectiveness research, 2021-10, Vol.10 (15), p.1121-1131

2021

Volltextzugriff (PDF)

The clinical and economic burden of newly diagnosed Alzheimer's disease in a medicare advantage population

American journal of Alzheimer's disease and other dementias, 2013-06, Vol.28 (4), p.384-392

2013

Volltextzugriff (PDF)

Impact of coexisting overactive bladder in Medicare patients with osteoporosis

Archives of gerontology and geriatrics, 2018-03, Vol.75, p.44-50

2018

Volltextzugriff (PDF)

Impact of a Step Therapy for Guanfacine Extended-Release on Medication Utilization and Health Care Expenditures Among Individuals Receiving Treatment for ADHD

Journal of managed care & specialty pharmacy, 2015-09, Vol.21 (9), p.793-802

2015

Volltextzugriff (PDF)

Novel Approach Using Administrative Claims to Evaluate Trends in Oncology Multigene Panel Testing for Patients Enrolled in Medicare Advantage Health Plans

JCO precision oncology, 2021, Vol.5 (5), p.792-801

2021

Volltextzugriff (PDF)

A Historical Retrospective Analysis of the Impact of Diabetes Quality Measure Attainment on Outcomes in Medicare Advantage Members

Population health management, 2017-04, Vol.20 (2), p.146-154

2017

Volltextzugriff (PDF)

Association of out-of-pocket pharmacy costs with adherence to varenicline

Journal of managed care & specialty pharmacy, 2014-06, Vol.20 (6), p.592-600

2014

Volltextzugriff (PDF)

A retrospective, matched cohort study of potential drug-drug interaction prevalence and opioid utilization in a diabetic peripheral neuropathy population initiated on pregabalin or duloxetine

BMC health services research, 2015-04, Vol.15 (1), p.159-159, Article 159

2015

Volltextzugriff (PDF)

Impact of a Pregabalin Step Therapy Policy Among Medicare Advantage Beneficiaries

Pain practice, 2014-06, Vol.14 (5), p.419-426

2014

Volltextzugriff (PDF)

Impact of Overactive Bladder Step Therapy Policies on Medication Utilization and Expenditures Among Treated Medicare Members

Journal of managed care & specialty pharmacy, 2017-01, Vol.23 (1), p.27-37

2017

Volltextzugriff (PDF)

Erratum to: A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance

Drug safety, 2015-08, Vol.38 (8), p.767-768

2015

Volltextzugriff (PDF)

Duloxetine hydrochloride: A new dual-acting medication for the treatment of major depressive disorder

Clinical therapeutics, 2005-08, Vol.27 (8), p.1126-1143

2005

Volltextzugriff (PDF)

Impact of a step-therapy protocol for pregabalin on healthcare utilization and expenditures in a commercial population

Journal of medical economics, 2013-01, Vol.16 (6), p.784-792

2013

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(51)

Sprache

Englisch
(51)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Anticholinergic exposure and its association with dementia/Alzheimer's disease and mortality in older adults

A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance

The Relationship Between Anticholinergic Exposure and Falls, Fractures, and Mortality in Patients with Overactive Bladder

Association of obesity with healthcare utilization and costs in a Medicare population

Effect of Potentially Inappropriate Use of Antimuscarinic Medications on Healthcare Use and Cost in Individuals with Overactive Bladder

Heart Failure Among Patients with Multiple Myeloma Treated with Carfilzomib-Based Versus Non–Carfilzomib-Based Regimens in the United States by Race

Impact of 2015 Update to the Beers Criteria on Estimates of Prevalence and Costs Associated with Potentially Inappropriate Use of Antimuscarinics for Overactive Bladder

Retrospective evaluation of an inpatient psychiatric pharmacist consultation service

Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study

Household Members of Persons with Alzheimer's Disease: Health Conditions, Healthcare Resource Use, and Healthcare Costs

A prospective study of elderly initiating mirabegron versus antimuscarinics: Patient reported outcomes from the Overactive Bladder Satisfaction Scales and other instruments

Impact of Coexisting Overactive Bladder in Medicare Patients With Dementia on Clinical and Economic Outcomes

Real-world treatment, clinical outcomes and healthcare resource utilization among persons with hemophilia A by age

The clinical and economic burden of newly diagnosed Alzheimer's disease in a medicare advantage population

Impact of coexisting overactive bladder in Medicare patients with osteoporosis

Impact of a Step Therapy for Guanfacine Extended-Release on Medication Utilization and Health Care Expenditures Among Individuals Receiving Treatment for ADHD

Novel Approach Using Administrative Claims to Evaluate Trends in Oncology Multigene Panel Testing for Patients Enrolled in Medicare Advantage Health Plans

A Historical Retrospective Analysis of the Impact of Diabetes Quality Measure Attainment on Outcomes in Medicare Advantage Members

Association of out-of-pocket pharmacy costs with adherence to varenicline

A retrospective, matched cohort study of potential drug-drug interaction prevalence and opioid utilization in a diabetic peripheral neuropathy population initiated on pregabalin or duloxetine

Impact of a Pregabalin Step Therapy Policy Among Medicare Advantage Beneficiaries

Impact of Overactive Bladder Step Therapy Policies on Medication Utilization and Expenditures Among Treated Medicare Members

Erratum to: A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance

Duloxetine hydrochloride: A new dual-acting medication for the treatment of major depressive disorder

Impact of a step-therapy protocol for pregabalin on healthcare utilization and expenditures in a commercial population

Suchergebnisse filtern